Literature DB >> 19798124

Inhibition of tumor growth and induction of apoptosis in prostate cancer cell lines by overexpression of tissue inhibitor of matrix metalloproteinase-3.

L Zhang1, L Zhao, D Zhao, G Lin, B Guo, Y Li, Z Liang, X J Zhao, X Fang.   

Abstract

The destruction of extracellular matrix by matrix metalloproteinases is a key event in cancer progression. The tissue inhibitors of metalloproteinases can restrain tumor growth by inhibiting these enzymes. We sought to determine whether overexpression of tissue inhibitor of metalloproteinase-3 (TIMP-3) could suppress the malignant phenotype of human prostate cancer cell line PC-3M. Stable overexpression of TIMP-3 inhibited cell proliferation significantly by MTT assay. Both early and late apoptosis were observed in TIMP-3 overexpressing cells, and flow cytometry analysis showed S-phase blocking of the cell cycle. Monolayer invasion assay and transwell invasion assay showed significantly decreased invasive potential in TIMP-3 overexpressing cells compared with control cells. Cell adhesion and motility were also lower after TIMP-3 was overexpressed. In vivo, cells stably overexpressing TIMP-3 completely lost the ability to form tumors after injection into nude mice. Transfection of TIMP-3 into established tumors by electroporation also had a significant antitumor effect. TIMP-3-treated tumor tissues had significant apoptosis by TUNEL assay. These results showed that overexpression of TIMP-3 inhibits invasion and proliferation of prostate cancer cells in vitro and inhibits tumor growth in vivo. The experiments suggest a potential use for TIMP-3 in the gene therapy of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19798124     DOI: 10.1038/cgt.2009.59

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  12 in total

1.  Heterogeneous epigenetic regulation of TIMP3 in prostate cancer.

Authors:  Toshiaki Shinojima; Qiang Yu; Sharon K Huang; Michelle Li; Ryuichi Mizuno; Edison T Liu; Dave S B Hoon; Laurent Lessard
Journal:  Epigenetics       Date:  2012-09-28       Impact factor: 4.528

2.  Plasmid-based Stat3 siRNA delivered by hydroxyapatite nanoparticles suppresses mouse prostate tumour growth in vivo.

Authors:  Zuo-Wen Liang; Bao-Feng Guo; Yang Li; Xiao-Jie Li; Xin Li; Li-Jing Zhao; Li-Fang Gao; Hao Yu; Xue-Jian Zhao; Ling Zhang; Bao-Xue Yang
Journal:  Asian J Androl       Date:  2011-02-07       Impact factor: 3.285

3.  Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth.

Authors:  Yan-Bo Liu; Ling Zhang; Ya-Xiong Guo; Li-Fang Gao; Xi-Chun Liu; Li-Juan Zhao; Bao-Feng Guo; Li-Jing Zhao; Xue-Jian Zhao; De-Qi Xu
Journal:  Asian J Androl       Date:  2012-05-14       Impact factor: 3.285

4.  Timp3 deficient mice show resistance to developing breast cancer.

Authors:  Hartland W Jackson; Carlo V Hojilla; Ashley Weiss; Otto H Sanchez; Geoffrey A Wood; Rama Khokha
Journal:  PLoS One       Date:  2015-03-25       Impact factor: 3.240

5.  Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.

Authors:  Mujeeb Zafar Banday; Aga Syed Sameer
Journal:  Biosci Rep       Date:  2019-05-10       Impact factor: 3.840

6.  TIMP-3 expression associates with malignant behaviors and predicts favorable survival in HCC.

Authors:  Xuefeng Gu; Maoying Fu; Yuqin Ding; Huihui Ni; Wei Zhang; Yanfang Zhu; Xiaojun Tang; Lin Xiong; Jiang Li; Liang Qiu; Jiaren Xu; Jin Zhu
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

7.  Sphingosine-1-phosphate suppresses chondrosarcoma metastasis by upregulation of tissue inhibitor of metalloproteinase 3 through suppressing miR-101 expression.

Authors:  Chun-Hao Tsai; Dong-Ying Yang; Chih-Yang Lin; Tsung-Ming Chen; Chih-Hsin Tang; Yuan-Li Huang
Journal:  Mol Oncol       Date:  2017-08-08       Impact factor: 6.603

8.  Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) induces FAS dependent apoptosis in human vascular smooth muscle cells.

Authors:  William R English; Heather Ireland-Zecchini; Andrew H Baker; Trevor D Littlewood; Martin R Bennett; Gillian Murphy
Journal:  PLoS One       Date:  2018-04-04       Impact factor: 3.240

9.  Loss of TIMP3 by promoter methylation of Sp1 binding site promotes oral cancer metastasis.

Authors:  Chun-Wen Su; Yu-Chao Chang; Ming-Hsien Chien; Yi-Hsien Hsieh; Mu-Kuan Chen; Chiao-Wen Lin; Shun-Fa Yang
Journal:  Cell Death Dis       Date:  2019-10-17       Impact factor: 8.469

10.  Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer.

Authors:  Chun-Wen Su; Yi-Wen Huang; Mu-Kuan Chen; Shih-Chi Su; Shun-Fa Yang; Chiao-Wen Lin
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.